Ignite Creation Date:
2024-05-06 @ 10:38 AM
Last Modification Date:
2024-10-26 @ 12:33 PM
Study NCT ID:
NCT03311542
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2018-01-10
First Post:
2017-10-12
Brief Title:
Expanded Access for Pembrolizumab MK-3475
Sponsor:
Center Trials Treatment
Organization:
Center Trials Treatment